" Now how about we all go back to discussing something that is easy to agree on, and that is why PNV is headed for $4 and beyond"
I agree entirely with you TA007. PNV is currently growing at about 60%pa. If we project the share price over 5 years at that growth rate, it comes to about $24 (Get calculator, type in 1.6x2.33 and press the = sign 5 times). Additionally, the 60% growth rate largely excludes India, with France, Japan, China, South Korea and other countries (DW is looking at Indonesia) that are due to come onboard during that 5 year period. I know that it takes about 18 months to gain traction but even so, not only is the 60% maintainable but it could increase as some of these other countries have huge populations (eg. India and China both greater than 1.4 billion and Indonesia 280 million). I seems to me that the $24 share price in 5 years time is at the lower limit of what is possible.
- Forums
- ASX - By Stock
- PNV
- PNV - Banter and General Comments
PNV
polynovo limited
Add to My Watchlist
2.58%
!
$1.20

PNV - Banter and General Comments, page-11600
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.20 |
Change
0.030(2.58%) |
Mkt cap ! $825.5M |
Open | High | Low | Value | Volume |
$1.19 | $1.22 | $1.18 | $2.173M | 1.811M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 26000 | $1.19 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.21 | 10000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 26000 | 1.190 |
1 | 2308 | 1.185 |
1 | 10000 | 1.175 |
4 | 25365 | 1.170 |
1 | 10004 | 1.165 |
Price($) | Vol. | No. |
---|---|---|
1.205 | 10000 | 1 |
1.210 | 24018 | 4 |
1.215 | 13379 | 3 |
1.220 | 16190 | 2 |
1.225 | 2000 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
PNV (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online